Correlation Between Johnson Johnson and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Processa Pharmaceuticals, you can compare the effects of market volatilities on Johnson Johnson and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Processa Pharmaceuticals.
Diversification Opportunities for Johnson Johnson and Processa Pharmaceuticals
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Johnson and Processa is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Johnson Johnson and Processa Pharmaceuticals
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.08 times more return on investment than Processa Pharmaceuticals. However, Johnson Johnson is 12.05 times less risky than Processa Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 15,300 in Johnson Johnson on August 31, 2024 and sell it today you would earn a total of 201.00 from holding Johnson Johnson or generate 1.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Processa Pharmaceuticals
Performance |
| Timeline |
| Johnson Johnson |
| Processa Pharmaceuticals |
Johnson Johnson and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Processa Pharmaceuticals
The main advantage of trading using opposite Johnson Johnson and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| Johnson Johnson vs. Pfizer Inc | Johnson Johnson vs. RLJ Lodging Trust | Johnson Johnson vs. Aquagold International | Johnson Johnson vs. Stepstone Group |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |